Dr. Krishna G. Putchakayala, MD

Dr. Putchakayala practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Putchakayala's NPI, 1902192628, was assigned on June 21, 2011. Dr. Putchakayala graduated from Northwestern University Feinberg Medical School in 2009. Dr. Putchakayala holds Michigan license 4301106311.

Dr. Putchakayala's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Putchakayala's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Putchakayala to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Putchakayala practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Putchakayala's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Putchakayala is licensed in Michigan.

CMS data shows 16 Medicare services from Dr. Putchakayala across 1 procedure code in 2024, for 48 Medicare patients. Medicare paid $28,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Putchakayala in 2024. The largest group is under 65, with 28 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 7.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Putchakayala's median patient age at 59, with 46% women.

In 2024, Dr. Putchakayala wrote 220 Medicare Part D claims for 36 patients. 91% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $2,117 in total drug cost. In 2023, CMS named 91 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Putchakayala for performance year 2024, reported as part of a group. Dr. Putchakayala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Putchakayala, published from 2014 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Graft Rejection and Kidney. Dr. Putchakayala's most frequent co-authors are Dean Y. Kim, MD, Lauren E. Malinzak, MD and Shunji Nagai, MD.

CMS Open Payments shows 3 general payments to Dr. Putchakayala from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $110.

Dr. Putchakayala graduated from Northwestern University Feinberg Medical School in 2009.